EXAS 精密科學

添加自選

62.070
+1.530+2.53%

收盤價 05/03 16:00 (美東)

62.580
+0.510+0.82%

盤後 18:22 (美東)

114.12億總市值-54929市盈率TTM

關於精密科學公司

Exact Sciences Corporation總部位於威斯康星州麥迪遜市，在美國和國際上提供癌症篩查和診斷測試產品。Exact的Cologuard篩查測試是一種基於糞便的無創DNA測試，是一種結腸癌、直腸癌的癌前篩查測試。該公司還與Oncotype DX在精確腫瘤市場展開競爭，Oncotype DX是一套基於組織的基因組測試，用於估計乳腺癌和結腸癌的復發風險和化療獲益的可能性，以及 OncoExTra 是一種基於液體的綜合基因組分析測試。該公司還正在開發用於分子殘留疾病、結直腸癌篩查和多癌篩查的液體活檢測試。

公司介紹

公司代碼EXAS

公司名稱精密科學

上市日期2001/01/31

發行價格14.00

成立日期1995

CEOMr. Kevin T. Conroy

所屬市場納斯達克

員工數量6600

證券類型海外普通股

年結日12-31

公司地址5505 Endeavor Lane

城市Madison

省份威斯康辛州

國家美國

郵編53719

電話1-608-284-5700

網址http://www.exactsciences.com

董事高管

姓名
職務
年薪

Kevin T. Conroy
Chairman of the Board, President and Chief Executive Officer
1611.99萬

Jeffrey T. Elliott
Executive Vice President, Chief Financial Officer, Chief Operating Officer and Principal Accounting Officer
407.77萬

Everett V. Cunningham
Executive Vice President and Chief Commercial Officer
454.70萬

Brian Baranick
Executive Vice President and General Manager, Precision Oncology
357.40萬

Jacob Orville
Executive Vice President and General Manager, Screening
366.83萬

James Herriott
Senior Vice President, General Counsel and Secretary
--

Sarah Condella
Executive Vice President, Human Resources
--

Aaron Bloomer
Executive Vice President, Finance
--

Scott D. Coward
Director
147.49萬

Kathleen Sebelius
Independent Director
41.17萬

Daniel Joseph Levangie
Independent Director
40.87萬

Dr. Freda C. Lewis-Hall,M.D.
Independent Director
40.27萬

James E. Doyle
Lead Independent Director
44.27萬

Shacey Petrovic
Independent Director
40.12萬

Pierre Jacquet
Independent Director
40.12萬

Michael J. Barber
Independent Director
--

Katherine S. Zanotti
Independent Director
40.62萬

Paul J. Clancy
Independent Director
41.77萬

Timothy John Scannell
Independent Director
36.28萬

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議

美股

綜合熱度

所屬概念

抗癌醫藥

今日-0.07%